ArticleJornal brasileiro de nefrologia

mTOR inhibitors are the first-choice therapy for renal angiomyolipomas secondary to tuberous sclerosis.

Aline Grosskopf Monich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.